0 Microbiology Society Annual Conference: highlights in brief
Discover our highlights and key takeaways from the Microbiology Society Annual Conference with our Editor, Martha Powell, who runs through some of our favorite talks.
Browsing: Disease Area > Viral
0 Single dose of genetically-altered broadly-neutralizing antibodies SHIV-protective in monkeys
Two genetically-modified broadly-neutralizing antibodies have been demonstrated to elicit long-term protection against an HIV-like virus in rhesus macaques, with a Phase I clinical trial now underway.
0 Novel strategy offers yellow fever vaccine for almost 1 billion individuals in Africa by 2026
A novel initiative is working to ensure that approximately 1 billion individuals are vaccinated against yellow fever across 27 African countries by 2026.
0 Advances in vaccine manufacturing – a step toward recombinant production
Take a look at how advancements in genetic engineering has led to advances in vaccine manufacturing, with a divergence from live cell cultures to recombinant production in host cells.
0 Do HIV-associated neurological disorders have shared mechanisms with Alzheimer’s disease?
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
0 Should infants with postnatal Zika infection be monitored long-term?
With Zika research primarily focusing on in utero infections, new work has used a monkey model to study infants infected in their first year of life, uncovering adverse neurological consequences.
0 FDA approval for new once-daily HIV treatment Symfi™
Mylan N.V have announced they’ll be launching their third HIV combination in the US, following FDA approval of their once-daily treatment Symfi™.
0 HIV and TB: the ongoing challenge of the two epidemics
TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
0 Roche launches new IgG Zika assay, Elecsys®
Roche has this week announced the launch of a new fully-automated IgG Zika assay, Elecsys®, which it hopes will help address the urgent need for accurate Zika diagnosis.
0 Study estimates the neurological risks of Zika virus infection amongst unborn children
A recent study has presented an accurate estimation of pregnancy outcomes associated with Zika infection in French territories in the Americas.
